Skip to main content

Advertisement

Log in

Resveratrol mitigates genotoxicity induced by iodine-131 in primary human lymphocytes

  • Short Communication
  • Published:
Radiation and Environmental Biophysics Aims and scope Submit manuscript

Abstract

The purpose of this study was to investigate the radioprotective effects of resveratrol as a natural product that protects against genotoxic actions of 131I in cultured human lymphocytes. Whole-blood samples from human volunteers were treated with resveratrol at doses of 0.5, 1, 5, and 50 μg/mL for 1 h, after which the lymphocytes were incubated with 131I (100 μCi/1.5 mL) for 2 h. The lymphocyte cultures were then mitogenically stimulated to enable evaluation of the number of micronuclei in cytokinesis-blocked binucleated cells. Incubation of lymphocytes with 131I induced genotoxicity, which was reflected by an increase in micronuclei frequency. At the doses tested, resveratrol significantly reduced micronuclei frequency. Maximal protective effects occurred at a dose of 1 μg/mL, with total micronuclei values being reduced by 65 % compared to controls. In conclusion, our results indicate protective effects of resveratrol at low doses against genetic damage and adverse effects induced by 131I administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  • Ballardin M, Gemignani F, Bodei L, Mariani G, Ferdeghini M, Rossi AM, Migliore L, Barale R (2002) Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131. Mutat Res 514(1–2):77–85

    Google Scholar 

  • Bisht K, Wagner KH, Bulmer AC (2010) Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology 278(1):88–100

    Article  Google Scholar 

  • Csiszar A (2011) Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease. Ann N Y Acad Sci 1215:117–122

    Article  ADS  Google Scholar 

  • de Vathaire F, Schlumberger M, Delisle MJ, Francese C, Challeton C, de la Genardiere E, Meunier F, Parmentier C, Hill C, Sancho-Garnier H (1997) Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer 75(5):734–739

    Article  Google Scholar 

  • Edmonds CJ, Smith T (1986) The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 59(697):45–51

    Article  Google Scholar 

  • Fallahi B, Adabi K, Majidi M, Fard-Esfahani A, Heshmat R, Larijani B, Haghpanah V (2011) Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment. Clin Nucl Med 36(4):277–282

    Article  Google Scholar 

  • Fenech M (2000) The in vitro micronucleus technique. Mutat Res 455(1–2):81–95

    Google Scholar 

  • Fernandez AF, Fraga MF (2011) The effects of the dietary polyphenol resveratrol on human healthy aging and lifespan. Epigenetics 6(7):870–874

    Article  Google Scholar 

  • Frombaum M, Le Clanche S, Bonnefont-Rousselot D, Borderie D (2012) Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and *NO bioavailability: potential benefits to cardiovascular diseases. Biochimie 94(2):269–276

    Article  Google Scholar 

  • Gutierrez S, Carbonell E, Galofre P, Creus A, Marcos R (1997) Micronuclei induction by 131I exposure: study in hyperthyroidism patients. Mutat Res 373(1):39–45

    Article  Google Scholar 

  • Gutierrez S, Carbonell E, Galofre P, Creus A, Marcos R (1999) Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer. A study using the micronucleus test. Eur J Nucl Med 26(12):1589–1596

    Article  Google Scholar 

  • Hosseinimehr SJ (2009) Potential utility of radioprotective agents in the practice of nuclear medicine. Cancer Biother Radiopharm 24(6):723–731

    Article  Google Scholar 

  • Hosseinimehr SJ (2010) Flavonoids and genomic instability induced by ionizing radiation. Drug Discov Today 15(21–22):907–918

    Article  Google Scholar 

  • Huang X, Zhu HL (2011) Resveratrol and its analogues: promising antitumor agents. Anticancer Agents Med Chem 11(5):479–490

    Article  MathSciNet  Google Scholar 

  • Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I (2011) Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer 117(19):4439–4446

    Article  Google Scholar 

  • Kang HJ, Youn YK, Hong MK, Kim LS (2011) Antiproliferation and redifferentiation in thyroid cancer cell lines by polyphenol phytochemicals. J Korean Med Sci 26(7):893–899

    Article  Google Scholar 

  • Kim MY (2012) Nitric oxide triggers apoptosis in A375 human melanoma cells treated with capsaicin and resveratrol. Mol Med Report 5(2):585–591

    Google Scholar 

  • Kolade VO, Bosinski TJ, Ruffy EL (2005) Acute promyelocytic leukemia after iodine-131 therapy for Graves’ disease. Pharmacotherapy 25(7):1017–1020

    Article  Google Scholar 

  • Liao PC, Ng LT, Lin LT, Richardson CD, Wang GH, Lin CC (2010) Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells. J Med Food 13(6):1415–1423

    Article  Google Scholar 

  • Lin H, Xiong W, Zhang X, Liu B, Zhang W, Zhang Y, Cheng J, Huang H (2011) Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Oncol Rep 26(4):925–930

    Google Scholar 

  • Little JB (2000) Radiation carcinogenesis. Carcinogenesis 21(3):397–404

    Article  MathSciNet  Google Scholar 

  • Monteiro Gil O, Oliveira NG, Rodrigues AS, Laires A, Ferreira TC, Limbert E, Leonard A, Gerber G, Rueff J (2000) Cytogenetic alterations and oxidative stress in thyroid cancer patients after iodine-131 therapy. Mutagenesis 15(1):69–75

    Article  Google Scholar 

  • Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, Zhao S, Tamaki N, Noguchi Y, Noguchi S (2005) Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med 46(2):261–266

    Google Scholar 

  • Robbins RJ, Schlumberger MJ (2005) The evolving role of (131)I for the treatment of differentiated thyroid carcinoma. J Nucl Med 46(Suppl 1):28S–37S

    Google Scholar 

  • Sawka AM, Thabane L, Parlea L, Ibrahim-Zada I, Tsang RW, Brierley JD, Straus S, Ezzat S, Goldstein DP (2009) Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid 19(5):451–457

    Article  Google Scholar 

  • Schroeder T, Kuendgen A, Kayser S, Kroger N, Braulke F, Platzbecker U, Klarner V, Zohren F, Haase D, Stadler M et al (2012) Therapy-related myeloid neoplasms following treatment with radioiodine. Haematologica 97(2):206–212

    Article  Google Scholar 

  • Sebai H, Hovsepian S, Ristorcelli E, Aouani E, Lombardo D, Fayet G (2010) Resveratrol increases iodide trapping in the rat thyroid cell line FRTL-5. Thyroid 20(2):195–203

    Article  Google Scholar 

  • Sebastia N, Montoro A, Montoro A, Almonacid M, Villaescusa JI, Cervera J, Such E, Silla A, Soriano JM (2011) Assessment in vitro of radioprotective efficacy of curcumin and resveratrol. Radiat Meas 46(9):962–966

    Article  Google Scholar 

  • Shi Y, Yang S, Troup S, Lu X, Callaghan S, Park DS, Xing Y, Yang X (2011) Resveratrol induces apoptosis in breast cancer cells by E2F1-mediated up-regulation of ASPP1. Oncol Rep 25(6):1713–1719

    Google Scholar 

  • Shih A, Davis FB, Lin HY, Davis PJ (2002) Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J Clin Endocrinol Metab 87(3):1223–1232

    Article  Google Scholar 

  • Szekeres T, Saiko P, Fritzer-Szekeres M, Djavan B, Jager W (2011) Chemopreventive effects of resveratrol and resveratrol derivatives. Ann NY Acad Sci 1215:89–95

    Article  ADS  Google Scholar 

  • Truong M, Cook MR, Pinchot SN, Kunnimalaiyaan M, Chen H (2011) Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer. Ann Surg Oncol 18(5):1506–1511

    Article  Google Scholar 

  • Watanabe N, Kanegane H, Kinuya S, Shuke N, Yokoyama K, Kato H, Tomizawa G, Shimizu M, Funada H, Seto H (2004) The radiotoxicity of 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes. J Nucl Med 45(4):608–611

    Google Scholar 

  • Wood LG, Wark PA, Garg ML (2010) Antioxidant and anti-inflammatory effects of resveratrol in airway disease. Antioxid Redox Signal 13(10):1535–1548

    Article  Google Scholar 

  • Zhu X, Liu Q, Wang M, Liang M, Yang X, Xu X, Zou H, Qiu J (2011) Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts. PLoS ONE 6(11):e27081

    Article  ADS  Google Scholar 

Download references

Acknowledgments

This research was the subject of a Pharm D thesis of Monireh Hedayati as a student of Mazandaran University of Medical Sciences. It was supported by Mazandaran University of Medical Sciences.

Conflict of interest

The authors declared no potential conflict of interest with respect to the research, authorship, and/or publication of this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seyed Jalal Hosseinimehr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hedayati, M., Shafaghati, N. & Hosseinimehr, S.J. Resveratrol mitigates genotoxicity induced by iodine-131 in primary human lymphocytes. Radiat Environ Biophys 52, 287–291 (2013). https://doi.org/10.1007/s00411-013-0461-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00411-013-0461-1

Keywords

Navigation